Unigestion Holding Sa United Therapeutics Corp Transaction History

Unigestion Holding Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$179.86 - $214.88 $858,471 - $1.03 Million	-4,773 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$170.47 - $211.93 $191,267 - $237,785	1,122 Added 30.73%	4,773 $845,000
Q1 2021 May 05, 2021	BUY	$153.94 - $174.85 $562,034 - $638,377	3,651 New	3,651 $611,000
Q3 2019 Nov 04, 2019	SELL	$74.85 - $85.99 $739,443 - $849,495	-9,879 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$76.06 - $120.81 $751,396 - $1.19 Million	9,879 New	9,879 $771,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.